Methods for time‐varying exposure related problems in pharmacoepidemiology: An overview
Open Access
- 28 December 2017
- journal article
- review article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 27 (2) , 148-160
Abstract
Purpose: Lack of control for time‐varying exposures can lead to substantial bias in estimates of treatment effects. The aim of this study is to provide an overview and guidance on some of the available methodologies used to address problems related to time‐varying exposure and confounding in pharmacoepidemiology and other observational studies. The methods are explored from a conceptual rather than an analytical perspective.Methods: The methods described in this study have been identified exploring the literature concerning to the time‐varying exposure concept and basing the search on four fundamental pharmacoepidemiological problems, construction of treatment episodes, time‐varying confounders, cumulative exposure and latency, and treatment switching.Results: A correct treatment episodes construction is fundamental to avoid bias in treatment effect estimates. Several methods exist to address time‐varying covariates, but the complexity of the most advanced approaches—eg, marginal structural models or structural nested failure time models—and the lack of user‐friendly statistical packages have prevented broader adoption of these methods. Consequently, simpler methods are most commonly used, including, for example, methods without any adjustment strategy and models with time‐varying covariates. The magnitude of exposure needs to be considered and properly modelled.Conclusions: Further research on the application and implementation of the most complex methods is needed. Because different methods can lead to substantial differences in the treatment effect estimates, the application of several methods and comparison of the results is recommended. Treatment episodes estimation and exposure quantification are key parts in the estimation of treatment effects or associations of interest.Keywords
Funding Information
- Novo Nordisk (NNF15SA0018404)
This publication has 52 references indexed in Scilit:
- Paxillin is an intrinsic negative regulator of platelet activation in miceThrombosis Journal, 2014
- Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysisAnnals of the Rheumatic Diseases, 2012
- CommentaryEpidemiology, 2012
- A Comparison of Standard Methods With G-estimation of Accelerated Failure-time Models to Address The Healthy-worker Survivor EffectEpidemiology, 2012
- Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population‐based study from FinlandPharmacoepidemiology and Drug Safety, 2010
- Relation between three classes of structural models for the effect of a time-varying exposure on survivalLifetime Data Analysis, 2009
- Flexible modeling of the cumulative effects of time‐dependent exposures on the hazardStatistics in Medicine, 2009
- Latency Models for Analyses of Protracted ExposuresEpidemiology, 2009
- Using tensor product splines in modeling exposure–time–response relationships: Application to the Colorado Plateau Uranium Miners cohortStatistics in Medicine, 2008
- Using prescription registries to define continuous drug use: how to fill gaps between prescriptionsPharmacoepidemiology and Drug Safety, 2008